Affordable Access

Access to the full text

Assessment of Outcomes Associated With the Use of Newly Approved Oncology Drugs in Medicare Beneficiaries

Authors
  • Green, Angela K.1, 2
  • Curry, Michael2
  • Trivedi, Niti2
  • Bach, Peter B.2
  • Mailankody, Sham2, 3
  • 1 Gynecologic Medical Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
  • 2 Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center, New York, New York
  • 3 Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
Type
Published Article
Journal
JAMA Network Open
Publisher
American Medical Association
Publication Date
Feb 24, 2021
Volume
4
Issue
2
Identifiers
DOI: 10.1001/jamanetworkopen.2021.0030
PMID: 33625507
PMCID: PMC7905499
Source
PubMed Central
License
Green
External links

Abstract

This cohort study evaluates the differences in survival, duration of therapy, and treatment patterns between clinical trial patients and older adults with Medicare receiving cancer drugs for metastatic solid cancers in usual practice.

Report this publication

Statistics

Seen <100 times